Robert Levy
Hematology & Oncology · Middletown, CTNPI 1467559856
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,030 of the $1,418 with a category attached, or 72.7%. 25 manufacturers reported payments, led by Boston Scientific at 25.9% of the total. Reporting peaked in 2024 at $903 and has fallen 73.4% since, to $240 in 2025. That places this record below the midpoint for hematology & oncology clinicians in CT, where the typical reported total is $1,376.
Across 48 payments — averaging $29.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$367
- Johnson & Johnson$137
- E.r. Squibb & Sons, L.L.C.$127
- Taiho Oncology, Inc.$104
- Novartis$82
- Sanofi$79
- plus $522 from 19 others
Across 64 payments — averaging $649.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$37K
- Novartis$5K
What the payments were for
- Travel & lodging$33424%
- Food & beverage$1,03073%
- Education$544%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORISE$334
How this compares
$1,418 in reported general payments places this provider in the 50th percentile of 163 hematology & oncology providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $22,568 |
| Abiraterone Acetate | 13 | $6,051 |
| Tamoxifen Citrate | 24 | $871 |
| Anastrozole | 33 | $870 |
| Acyclovir | 21 | $306 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Middletown
- Amer ZeidanNew Haven$807K
- Biree AndemariamFarmington$646K
- Paul WeinsteinStamford$288K
- Walid ShaibNew Haven$217K
- Madhavi GorusuHartford$207K
- Dinesh KapurNorwich$201K
- Scott HuntingtonNew Haven$163K
- Nataliya UbohaNew Haven$124K
- Michael CecchiniNew Haven$103K
- Justine RyuOrange$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.